Breaking News
22 hours ago
Vaibhavi M.
Horphag Research advances Pycnogenol® as a multi-claim women's health ingredient backed by 160+ clinical studies across skin, menopause, circulation, and joints.
Vaibhavi M.
Koi Peptides releases a lyophilized BPC-157/TB-500 research blend with per-lot CoA documentation for laboratory traceability.
Vaibhavi M.

FibroBiologics doses first patients in CYWC628 Phase 1/2 DFU trial while advancing a third consecutive GMP manufacturing run.
Vaibhavi M.

FDA approves Amphastar's Rextovy 4mg OTC naloxone nasal spray, adding a second nonprescription option and raising manufacturing scale-up questions.
Vaibhavi M.
